Business Description
Enzychem Lifesciences Corp
ISIN : KR7183490002
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 24.28 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.98 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 7.6 | |||||
Beneish M-Score | 0.37 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 28.9 | |||||
3-Year EBITDA Growth Rate | 35.7 | |||||
3-Year EPS without NRI Growth Rate | 27.8 | |||||
3-Year FCF Growth Rate | 18.9 | |||||
3-Year Book Growth Rate | 25.3 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.54 | |||||
9-Day RSI | 50.06 | |||||
14-Day RSI | 53.47 | |||||
6-1 Month Momentum % | 31.75 | |||||
12-1 Month Momentum % | 3.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 12.33 | |||||
Quick Ratio | 11.27 | |||||
Cash Ratio | 9.7 | |||||
Days Inventory | 66.73 | |||||
Days Sales Outstanding | 43.8 | |||||
Days Payable | 21.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.8 | |||||
Shareholder Yield % | 25.67 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 5.72 | |||||
Operating Margin % | -18.88 | |||||
Net Margin % | -12.27 | |||||
FCF Margin % | -16.52 | |||||
ROE % | -4.73 | |||||
ROA % | -4.2 | |||||
ROIC % | -22.72 | |||||
ROC (Joel Greenblatt) % | -21.69 | |||||
ROCE % | -4.58 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.18 | |||||
PB Ratio | 0.86 | |||||
Price-to-Tangible-Book | 0.89 | |||||
EV-to-EBIT | -3.78 | |||||
EV-to-EBITDA | -6.08 | |||||
EV-to-Revenue | 0.47 | |||||
EV-to-FCF | -3.43 | |||||
Price-to-Net-Current-Asset-Value | 1.07 | |||||
Price-to-Net-Cash | 1.4 | |||||
Earnings Yield (Greenblatt) % | -26.47 | |||||
FCF Yield % | -7.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Enzychem Lifesciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 76,038.894 | ||
EPS (TTM) (â‚©) | -110 | ||
Beta | 1.45 | ||
Volatility % | 53.72 | ||
14-Day RSI | 53.47 | ||
14-Day ATR (â‚©) | 90.861508 | ||
20-Day SMA (â‚©) | 1892.9 | ||
12-1 Month Momentum % | 3.5 | ||
52-Week Range (â‚©) | 1110 - 2220 | ||
Shares Outstanding (Mil) | 85.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Enzychem Lifesciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Enzychem Lifesciences Corp Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Enzychem Lifesciences Corp Frequently Asked Questions
What is Enzychem Lifesciences Corp(XKRX:183490)'s stock price today?
When is next earnings date of Enzychem Lifesciences Corp(XKRX:183490)?
Does Enzychem Lifesciences Corp(XKRX:183490) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |